trending Market Intelligence /marketintelligence/en/news-insights/trending/wSggQI-bRU9WcAiPktNzKQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Qiagen sells NeXtal Biotechnologies unit to Calibre Scientific

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Qiagen sells NeXtal Biotechnologies unit to Calibre Scientific

Los Angeles-based Calibre Scientific Inc. acquired Qiagen NV's NeXtal Biotechnologies unit, which specializes in producing protein crystallization plates and screens.

NeXtal's products are sold in the academic, biotechnology and pharmaceutical markets and are used to study the molecular structure of a protein, primarily for creating certain medicines including cancer treatments.

Calibre Scientific CEO Ben Travis said NeXtal's proprietary products complement its offerings.

Financial details of the transaction were not disclosed.

NeXtal Biotechnologies was acquired by Qiagen in 2005 for $14.2 million.